Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 14 de 14
Filter
Add more filters










Publication year range
1.
PLoS One ; 15(12): e0242874, 2020.
Article in English | MEDLINE | ID: mdl-33284816

ABSTRACT

Preimplantation factor (PIF) is an embryo derived peptide which exerts an immune modulatory effect on human endometrium, promoting immune tolerance to the embryo whilst maintaining the immune response to invading pathogens. While bovine embryos secrete PIF, the effect on the bovine endometrium is unknown. Maternal recognition of pregnancy is driven by an embryo-maternal cross talk, however the process differs between humans and cattle. As many embryos are lost during the early part of pregnancy in cattle, a greater knowledge of factors affecting the embryo-maternal crosstalk, such as PIF, is needed to improve fertility. Therefore, for the first time, we demonstrate the effect of synthetic PIF (sPIF) on the bovine transcriptome in an ex vivo bovine endometrial tissue culture model. Explants were cultured for 30h with sPIF (100nM) or in control media. Total RNA was analysed via RNA-sequencing. As a result of sPIF treatment, 102 genes were differentially expressed compared to the control (Padj<0.1), although none by more than 2-fold. The majority of genes (78) were downregulated. Pathway analysis revealed targeting of several immune based pathways. Genes for the TNF, NF-κB, IL-17, MAPK and TLR signalling pathways were down-regulated by sPIF. However, some immune genes were demonstrated to be upregulated following sPIF treatment, including C3. Steroid biosynthesis was the only over-represented pathway with all genes upregulated. We demonstrate that sPIF can modulate the bovine endometrial transcriptome in an immune modulatory manner, like that in the human endometrium, however, the regulation of genes was much weaker than in previous human work.


Subject(s)
Endometrium/drug effects , Endometrium/metabolism , Peptides/pharmacology , Transcriptome/drug effects , Animals , Cattle , Female , Gene Ontology , Progesterone/metabolism , Time Factors
2.
PLoS One ; 14(6): e0218412, 2019.
Article in English | MEDLINE | ID: mdl-31220119

ABSTRACT

The Consortium for Mouse Cell Line Authentication was formed to validate Short Tandem Repeat (STR) markers for intraspecies identification of mouse cell lines. The STR profiling method is a multiplex polymerase chain reaction (PCR) assay comprised of primers targeting 19 mouse STR markers and two human STR markers (for interspecies contamination screening). The goals of the Consortium were to perform an interlaboratory study to-(1) validate the mouse STR markers to uniquely identify mouse cell lines (intraspecies identification), (2) to provide a public database of mouse cell lines with the National Institute of Standards and Technology (NIST)-validated mouse STR profiles, and (3) to publish the results of the interlaboratory study. The interlaboratory study was an international effort that consisted of 12 participating laboratories representing institutions from academia, industry, biological resource centers, and government. The study was based on 50 of the most commonly used mouse cell lines obtained from the American Type Culture Collection (ATCC). Of the 50 mouse cell lines, 18 had unique STR profiles that were 100% concordant (match) among all Consortium laboratory members, and the remaining 32 cell lines had discordance that was resolved readily and led to improvement of the assay. The discordance was due to low signal and interpretation issues involving artifacts and genotyping errors. Although the total number of discordant STR profiles was relatively high in this study, the percent of labs agreeing on allele calls among the discordant samples was above 92%. The STR profiles, including electropherogram images, for NIST-validated mouse cell lines will be published on the NCBI BioSample Database (https://www.ncbi.nlm.nih.gov/biosample/). Overall, the interlaboratory study showed that the multiplex PCR method using 18 of the 19 mouse STR markers is capable of discriminating at the intraspecies level between mouse cell lines. Further studies are ongoing to refine the assay including (1) development of an allelic ladder for improving the accuracy of allele calling and (2) integration of stutter filters to identify true stutter.


Subject(s)
Genotype , Genotyping Techniques/methods , Microsatellite Repeats/genetics , Multiplex Polymerase Chain Reaction/methods , Alleles , Animals , Cell Line , Humans , Mice
3.
Theriogenology ; 102: 174-182, 2017 Oct 15.
Article in English | MEDLINE | ID: mdl-28800499

ABSTRACT

Preimplantation factor (PIF) is a pregnancy specific peptide with immune modulatory properties exerted on the human endometrium. Viable bovine embryos secrete PIF, but its effect on the bovine endometrial immune response is unknown, both in native and inflammatory stimulated endometrial tissue. An ex vivo bovine endometrial tissue culture model was used with lipopolysaccharide (LPS) as an inflammatory stimulant. The effect of synthetic PIF (sPIF) was assessed, in three separate experiments, on the secretion or mRNA expression of essential prostaglandins and cytokines. Radioimmunoassays were used to assess prostaglandin secretion and ELISA for IL-6 secretion from endometrial explants. mRNA expression of IL6 and IL8 was analysed from endometrial explants with real-time PCR. Synthetic PIF reduced native IL-6 secretion from explants when pre-treated for 24 h. There was no effect of sPIF on IL-6 secretion from LPS challenged explants; however, sPIF increased IL6 mRNA expression when challenged with 500 ng/mL LPS. There was no effect of sPIF on prostaglandin secretion or mRNA expression of IL8. Therefore, sPIF is able to modulate the native IL-6 production pathway in the bovine endometrium, yet demonstrates no effect on prostaglandin secretion or IL8 expression. Unlike in human studies, effects of sPIF were minimal, thus sPIF is not an effective modulator of the immune targets investigated in the bovine endometrium.


Subject(s)
Cattle , Dinoprost/metabolism , Dinoprostone/metabolism , Endometrium/metabolism , Interleukin-6/metabolism , Peptides/pharmacology , Animals , Dinoprost/genetics , Dinoprostone/genetics , Endometrium/drug effects , Female , Interleukin-6/genetics , Interleukin-8/genetics , Interleukin-8/metabolism , Pregnancy
4.
J Ethnopharmacol ; 209: 283-287, 2017 Sep 14.
Article in English | MEDLINE | ID: mdl-28789861

ABSTRACT

ETHNOPHARMACOLOGY RELEVANCE: Maytenus ilicifolia is a Celastracea plant used in traditional medicine to alleviate digestive tract inflammatory disorders. AIM OF THE STUDY: We investigated anti-inflammatory properties of M. ilicifolia crude extract towards Caco-2 cell line, as a model of Toll-like Receptor 2 (TLR-2) inflammatory pathway. MATERIALS AND METHODS: Toxicity was assessed following culture of Caco-2 with M. ilicifolia, using apparent cell permeability and trans-epithelial electric resistance. Anti-inflammatory properties of M. ilicifolia were assessed through IL-8 secretion and TLR-2 associated gene expression of Caco-2 cells with or without an LTA challenge. RESULTS: M. ilicifolia was not toxic to Caco-2 cells. M. ilicifolia down-regulated TLR2 expression with and without LTA challenge but had no effect on other genes. Following LTA challenge of Caco-2 cells, 100 and 200µg/mL M. ilicifolia abrogated IL-8 secretion. CONCLUSIONS: We provide preliminary data for some M. ilicifolia anti-inflammatory properties. Further research must establish the full extent and mode of action on particular inflammatory pathways.


Subject(s)
Anti-Inflammatory Agents/pharmacology , Epithelial Cells/drug effects , Intestinal Mucosa/cytology , Maytenus/chemistry , Plant Extracts/pharmacology , Anti-Inflammatory Agents/chemistry , Caco-2 Cells , Cytokines/genetics , Cytokines/metabolism , Gene Expression Regulation/drug effects , Humans , Plant Extracts/chemistry
5.
Eur J Pharm Biopharm ; 85(1): 20-5, 2013 Sep.
Article in English | MEDLINE | ID: mdl-23958315

ABSTRACT

BACKGROUND: CDX2 plays a key part in the differentiation of Caco-2 cells, a colon carcinoma derived cell line that undergoes spontaneous differentiation. The effect of CDX2 expression in Caco-2 cells over time in culture has not been studied yet on a genome-wide level. METHODS: The impact of CDX2 expression on the genomic profile of Caco-2 cells was studied by transducing cells with CDX2 targeting shRNAs. Knockdown efficiency was assessed on mRNA level and protein level by RTPCR, microarrays, and Western blots. Gene set enrichment analysis was performed to assess regulation of specific gene sets. RESULTS: CDX2 expression had an inhibitory effect on the transcriptional activity of ß-catenin/TCF at early stages of culturing, while at later stages, its role in the trans-activation of target genes specific for small intestinal enterocytes seemed more dominant. CONCLUSIONS: The unique induction of a small intestinal signature upon differentiation in Caco-2 cells seems to be at least partially under the control of CDX2.


Subject(s)
Cell Differentiation , Down-Regulation , Enterocytes/cytology , Homeodomain Proteins/metabolism , Transcriptional Activation , Up-Regulation , Wnt Signaling Pathway , CDX2 Transcription Factor , Caco-2 Cells , Chemotaxis , Databases, Genetic , Enterocytes/metabolism , Gene Expression Profiling , Genomics/methods , Homeodomain Proteins/antagonists & inhibitors , Homeodomain Proteins/genetics , Humans , Kinetics , RNA Interference , RNA, Messenger/metabolism , RNA, Small Interfering , TCF Transcription Factors/antagonists & inhibitors , TCF Transcription Factors/genetics , TCF Transcription Factors/metabolism , beta Catenin/antagonists & inhibitors , beta Catenin/genetics , beta Catenin/metabolism
6.
J Mater Chem B ; 1(38): 5128-5136, 2013 Oct 14.
Article in English | MEDLINE | ID: mdl-32261104

ABSTRACT

A droplet-based microfluidics technique is used to produce monodisperse, 80 µm collagen-gelatin beads with tunable mechanical properties in the range of 1-10 kPa after photo-crosslinking. The gel beads are porous, mechanically robust and stable in buffer, but can be degraded enzymatically. Encapsulated fibroblast cells maintain 70% viability after one-week encapsulation and preliminary results show that the degree of spreading of cells in gels is correlated with the stiffness of the material.

7.
PLoS One ; 7(9): e45513, 2012.
Article in English | MEDLINE | ID: mdl-23049808

ABSTRACT

BACKGROUND: Neuroblastoma (NB) is one of the most aggressive tumors that occur in childhood. Although genes, such as MYCN, have been shown to be involved in the aggressiveness of the disease, the identification of new biological markers is still desirable. The induction of differentiation is one of the strategies used in the treatment of neuroblastoma. A-type lamins are components of the nuclear lamina and are involved in differentiation. We studied the role of Lamin A/C in the differentiation and progression of neuroblastoma. METHODOLOGY/PRINCIPAL FINDINGS: Knock-down of Lamin A/C (LMNA-KD) in neuroblastoma cells blocked retinoic acid-induced differentiation, preventing neurites outgrowth and the expression of neural markers. The genome-wide gene-expression profile and the proteomic analysis of LMNA-KD cells confirmed the inhibition of differentiation and demonstrated an increase of aggressiveness-related genes and molecules resulting in augmented migration/invasion, and increasing the drug resistance of the cells. The more aggressive phenotype acquired by LMNA-KD cells was also maintained in vivo after injection into nude mice. A preliminary immunohistochemistry analysis of Lamin A/C expression in nine primary stages human NB indicated that this protein is poorly expressed in most of these cases. CONCLUSIONS/SIGNIFICANCE: We demonstrated for the first time in neuroblastoma cells that Lamin A/C plays a central role in the differentiation, and that the loss of this protein gave rise to a more aggressive tumor phenotype.


Subject(s)
Brain Neoplasms/genetics , Brain Neoplasms/pathology , Lamin Type A/genetics , Neuroblastoma/genetics , Neuroblastoma/pathology , Animals , Antibiotics, Antineoplastic/pharmacology , Brain Neoplasms/drug therapy , Brain Neoplasms/metabolism , Cell Differentiation/drug effects , Cell Line, Tumor , Cell Movement/drug effects , Doxorubicin/pharmacology , Drug Resistance, Neoplasm/drug effects , Drug Resistance, Neoplasm/genetics , Female , Gene Expression Profiling , Gene Expression Regulation, Neoplastic/drug effects , Gene Knockdown Techniques , Humans , Lamin Type A/antagonists & inhibitors , Lamin Type A/metabolism , Mice , Mice, Nude , Neoplasm Invasiveness , Neoplasm Transplantation , Neurites/drug effects , Neuroblastoma/drug therapy , Neuroblastoma/metabolism , Proteome/genetics , Proteome/metabolism , Tretinoin/pharmacology
8.
BMC Genomics ; 13: 274, 2012 Jun 22.
Article in English | MEDLINE | ID: mdl-22726358

ABSTRACT

BACKGROUND: The criteria for choosing relevant cell lines among a vast panel of available intestinal-derived lines exhibiting a wide range of functional properties are still ill-defined. The objective of this study was, therefore, to establish objective criteria for choosing relevant cell lines to assess their appropriateness as tumor models as well as for drug absorption studies. RESULTS: We made use of publicly available expression signatures and cell based functional assays to delineate differences between various intestinal colon carcinoma cell lines and normal intestinal epithelium. We have compared a panel of intestinal cell lines with patient-derived normal and tumor epithelium and classified them according to traits relating to oncogenic pathway activity, epithelial-mesenchymal transition (EMT) and stemness, migratory properties, proliferative activity, transporter expression profiles and chemosensitivity. For example, SW480 represent an EMT-high, migratory phenotype and scored highest in terms of signatures associated to worse overall survival and higher risk of recurrence based on patient derived databases. On the other hand, differentiated HT29 and T84 cells showed gene expression patterns closest to tumor bulk derived cells. Regarding drug absorption, we confirmed that differentiated Caco-2 cells are the model of choice for active uptake studies in the small intestine. Regarding chemosensitivity we were unable to confirm a recently proposed association of chemo-resistance with EMT traits. However, a novel signature was identified through mining of NCI60 GI50 values that allowed to rank the panel of intestinal cell lines according to their drug responsiveness to commonly used chemotherapeutics. CONCLUSIONS: This study presents a straightforward strategy to exploit publicly available gene expression data to guide the choice of cell-based models. While this approach does not overcome the major limitations of such models, introducing a rank order of selected features may allow selecting model cell lines that are more adapted and pertinent to the addressed biological question.


Subject(s)
Databases, Genetic , Models, Biological , Antineoplastic Agents/pharmacology , Caco-2 Cells , Cell Differentiation/drug effects , Cell Line, Tumor , Colonic Neoplasms/genetics , Colonic Neoplasms/metabolism , Drug Resistance, Neoplasm , Epithelial-Mesenchymal Transition/drug effects , Gene Expression Regulation, Neoplastic , HT29 Cells , Humans , Intestinal Mucosa/cytology , Intestinal Mucosa/metabolism , Principal Component Analysis
9.
Toxicol In Vitro ; 26(8): 1243-6, 2012 Dec.
Article in English | MEDLINE | ID: mdl-22465559

ABSTRACT

The human Caco-2 cells differentiate spontaneously in culture forming monolayers of mature intestinal enterocytes which have been used as a model of the intestinal barrier for in vitro toxicology studies. Reproducibility problems often reported in literature have been generally ascribed to different culture-related conditions, such as the type of animal serum used, the supplements added to the culture media, the passage number and the source of cell clones. The Caco-2 cell culture protocol here described has been recently optimized in our laboratory, producing a homogeneous and highly polarized monolayer of cells which display many of the characteristics of the intestinal enterocytes. This protocol differs from standard protocols mainly because Caco-2 cells are subcultured when they reach just 50% of confluence, instead of 80%, retaining a high proliferation potential. When this cell population is seeded at high density on filter inserts differentiates almost synchronously and much more homogenously.


Subject(s)
Cell Culture Techniques , Enterocytes/metabolism , Models, Biological , Animals , Caco-2 Cells , Cell Differentiation , Cell Proliferation , Cells, Cultured , Culture Media , Humans , Reproducibility of Results , Toxicology/methods
10.
Differentiation ; 83(3): 116-27, 2012 Mar.
Article in English | MEDLINE | ID: mdl-22364879

ABSTRACT

Caco-2 cancer cell line is widely used to reproduce in vitro the differentiation of absorptive enterocytes of human intestinal epithelium. This cell line, when cultured over confluence for 21 days, spontaneously undergoes cell cycle arrest and differentiates with the formation of a polarized enterocyte-like monolayer. During this process, Myc protein is completely down-regulated, as occurs in normal enterocytes. Caco-2 cells differ from normal enterocytes for mutations of APC and ß-catenin genes, factors known to be involved in the transcriptional control of MYC gene during enterocyte differentiation. In this paper, we investigated how Myc regulation could be achieved during Caco-2 differentiative process, notwithstanding the APC and ß-catenin mutations. We highlighted the post translational regulation of Myc protein as one of the essential mechanisms that allows the exit from cell cycle and onset of differentiation of Caco-2 cells. Moreover, we found a strong correlation between Myc protein downregulation and the expression of the transcription factor Cdx2, suggesting the existence of a regulative link between these two proteins.


Subject(s)
Cell Differentiation , Enterocytes/metabolism , Homeodomain Proteins/metabolism , Proto-Oncogene Proteins c-myc/metabolism , beta Catenin/metabolism , Adenomatous Polyposis Coli Protein/genetics , Adenomatous Polyposis Coli Protein/metabolism , CDX2 Transcription Factor , Caco-2 Cells , Cell Cycle/genetics , Enterocytes/cytology , Homeodomain Proteins/genetics , Humans , Intestines/cytology , Intestines/growth & development , Mutation , Proto-Oncogene Proteins c-myc/genetics , RNA Interference , beta Catenin/genetics
11.
Cell Cycle ; 10(24): 4311-20, 2011 Dec 15.
Article in English | MEDLINE | ID: mdl-22134239

ABSTRACT

The transcription factor hypoxia-inducible factor 1α (HIF-1α) is a master regulator of cell adaptation to decreasing oxygen levels. High oxygen tension promotes proteosomal degradation of HIF-1α via a pathway that requires hydroxylation of prolines 402 and 564. Low oxygen tension, hypoxia, inactivates the hydroxylases responsible for these modifications through a mechanism that is not fully understood but appears to require mitochondrial respiration and production of reactive oxygen species, ROS. Cells from individuals affected by ataxia telangiectasia syndrome have an impaired mitochondrial activity and a constitutive oxidative stress. Here we show that, in these cells, HIF-1α is efficiently degraded even in condition of low oxygen tension. Mechanistically this depends from a blunted increase in intracellular concentration of ROS in response to hypoxia which in turn is due to an increased cellular capacity of buffering ROS. We suggest that regulation of HIF-1α stability may depend on fold change of ROS relative to the basal level more than on their absolute value. Since elevated oxidative stress is a hallmark of many human disorders our finding may be relevant to different pathologies.


Subject(s)
Ataxia Telangiectasia/physiopathology , Hypoxia-Inducible Factor 1, alpha Subunit/metabolism , Mitochondria/metabolism , Oxidative Stress/physiology , Oxygen/metabolism , Cell Hypoxia/physiology , Flow Cytometry , Humans , Immunoblotting , Luciferases , Reactive Oxygen Species/metabolism , Reverse Transcriptase Polymerase Chain Reaction
12.
J Cell Physiol ; 226(6): 1531-43, 2011 Jun.
Article in English | MEDLINE | ID: mdl-20945374

ABSTRACT

The human intestinal Caco-2 cell line has been extensively used as a model of the intestinal barrier. However, it is widely reported in literature that culture-related conditions, as well as the different Caco-2 cell lines utilized in different laboratories, often lead to problems of reproducibility making difficult to compare results. We developed a new cell-maintenance protocol in which Caco-2 cells were subcultured at 50% of confluence instead of 80% of confluence, as usually suggested. Using this new protocol, Caco-2 cells retained a higher proliferation potential resulting in a cell population, which, on reaching confluence, was able to differentiate almost synchronously, forming a more homogeneous and polarized cell monolayer, as compared to that obtained using a high cell growing density. This comparison has been done by analyzing the gene expression and the structural characteristics of the 21-days differentiated monolayers by microarrays hybridization and by confocal microscopy. We then investigated if these differences could also modify the effects of toxicants on 21-days-differentiated cells. We analyzed the 2 h-acute toxicity of CuCl(2) in terms of actin depolymerization and metallothionein 2A (MT2A) and heat shock protein 70 (HSPA1A) genes induction. Copper treatment resulted in different levels of actin depolymerization and gene expression induction in relationship with culture protocol, the low-density growing cells showing a more homogeneous and stronger response. Our results suggest that cell growing density could influence a number of morphological and physiological properties of differentiated Caco-2 cells and these effects must be taken in account when these cells are used as intestinal model.


Subject(s)
Cell Differentiation , Biomarkers/metabolism , Caco-2 Cells , Cell Count , Cell Cycle/drug effects , Cell Cycle/genetics , Cell Cycle Proteins/genetics , Cell Cycle Proteins/metabolism , Cell Differentiation/drug effects , Cell Differentiation/genetics , Cell Membrane Permeability/drug effects , Cell Proliferation/drug effects , Cluster Analysis , Copper/toxicity , Enterocytes/cytology , Enterocytes/drug effects , Enterocytes/metabolism , Gene Expression Profiling , Gene Expression Regulation/drug effects , Humans , Membrane Proteins/metabolism , Microscopy, Confocal , Microvilli/drug effects , Microvilli/metabolism , Protein Transport/drug effects , Tight Junctions/drug effects , Tight Junctions/metabolism , Time Factors
13.
Toxicol In Vitro ; 23(8): 1510-5, 2009 Dec.
Article in English | MEDLINE | ID: mdl-19540330

ABSTRACT

Iron is used to cure iron-deficient anaemia but can also be toxic to the intestine. Fe(II) toxicity was investigated using differentiated human intestinal Caco-2 cells treated with 15 and 50 microM of Fe(II)/ascorbate for 2h (acute phase), and followed for 24h after iron removal and replacement of complete culture medium (late phase). During the acute phase damage to tight junctions occurred as demonstrated by an increase in cell monolayer permeability and by partial delocalization of the tight junction protein claudin 4 from the plasma membrane to an intracellular compartment. At the end of the late phase, cells treated with 15 microM Fe(II) showed full restoration of claudin 4 localization to the plasma membrane and their tight junction permeability returned to values close to those of control cells. Conversely, cells treated with 50 microM Fe(II) showed sustained and irreversible damage to the tight junctions, accompanied by apoptosis and necrosis. Activation of NF-kappaB occurred at both Fe(II) concentrations after 30 min of Fe(II) treatment, followed, at the end of the acute phase, by a strong induction of mRNA coding for heat shock protein 70 and metallothionein 2A. Our results indicate that intestinal cells respond to iron toxicity by strongly activating two genes involved in cell response to stress, although the outcome in terms of cell survival is different depending on the dose of treatment, namely almost complete restoration of epithelial permeability and cell survival at 15 microM Fe(II), and progressive and irreversible cytotoxicity leading to apoptosis and necrosis at 50 microM Fe(II).


Subject(s)
Iron/toxicity , Apoptosis/drug effects , Caco-2 Cells , Gene Expression Regulation/drug effects , HSP70 Heat-Shock Proteins/genetics , Humans , Metallothionein/genetics , NF-kappa B/metabolism , Necrosis , Oxidative Stress , Permeability , Tight Junctions/drug effects , Tight Junctions/metabolism
14.
PLoS One ; 4(5): e5442, 2009.
Article in English | MEDLINE | ID: mdl-19421315

ABSTRACT

BACKGROUND: The role of the MYC oncogene in the apoptotic pathways is not fully understood. MYC has been reported to protect cells from apoptosis activation but also to sensitize cells to apoptotic stimuli. We have previously demonstrated that the down-regulation of Myc protein activates apoptosis in melanoma cells and increases the susceptibility of cells to various antitumoral treatments. Beyond the well-known role in the G1-->S transition, MYC is also involved in the G2-M cell cycle phases regulation. METHODOLOGY/PRINCIPAL FINDINGS: In this study we have investigated how MYC could influence cell survival signalling during G2 and M phases. We used the microtubules damaging agent paclitaxel (PTX), to arrest the cells in the M phase, in a p53 mutated melanoma cell line with modulated Myc level and activity. An overexpression of Myc protein is able to increase endoreduplication favoring the survival of cells exposed to antimitotic poisoning. The PTX-induced endoreduplication is associated in Myc overexpressing cells with a reduced expression of MAD2, essential component of the molecular core of the spindle assembly checkpoint (SAC), indicating an impairment of this checkpoint. In addition, for the first time we have localized Myc protein at the spindle poles (centrosomes) during pro-metaphase in different cell lines. CONCLUSIONS: The presence of Myc at the poles during the prometaphase could be necessary for the Myc-mediated attenuation of the SAC and the subsequent induction of endoreduplication. In addition, our data strongly suggest that the use of taxane in antitumor therapeutic strategies should be rationally based on the molecular profile of the individual tumor by specifically analyzing Myc expression levels.


Subject(s)
Antineoplastic Agents, Phytogenic/pharmacology , Apoptosis/drug effects , DNA Replication/physiology , DNA, Neoplasm , Melanoma/genetics , Paclitaxel/pharmacology , Proto-Oncogene Proteins c-myc/physiology , Blotting, Western , Cell Division/drug effects , Cell Survival , Down-Regulation , G2 Phase/drug effects , Humans , Melanoma/pathology , Mitosis/drug effects , Spindle Apparatus/drug effects , Tumor Cells, Cultured
SELECTION OF CITATIONS
SEARCH DETAIL
...